vs

Side-by-side financial comparison of Civeo Corp (CVEO) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.

HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $161.6M, roughly 1.7× Civeo Corp). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -4.0%, a 4.7% gap on every dollar of revenue. On growth, Civeo Corp posted the faster year-over-year revenue change (7.1% vs -16.5%). Civeo Corp produced more free cash flow last quarter ($14.5M vs $3.4M).

The Civeo Corporation is an American accommodation services multinational corporation. It is a spin-off of Oil States International. It is a public company listed on the New York Stock Exchange.

HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.

CVEO vs HCM — Head-to-Head

Bigger by revenue
HCM
HCM
1.7× larger
HCM
$270.8M
$161.6M
CVEO
Growing faster (revenue YoY)
CVEO
CVEO
+23.6% gap
CVEO
7.1%
-16.5%
HCM
Higher net margin
HCM
HCM
4.7% more per $
HCM
0.7%
-4.0%
CVEO
More free cash flow
CVEO
CVEO
$11.1M more FCF
CVEO
$14.5M
$3.4M
HCM

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CVEO
CVEO
HCM
HCM
Revenue
$161.6M
$270.8M
Net Profit
$-6.5M
$2.0M
Gross Margin
22.7%
37.7%
Operating Margin
-0.1%
-13.2%
Net Margin
-4.0%
0.7%
Revenue YoY
7.1%
-16.5%
Net Profit YoY
58.1%
-83.6%
EPS (diluted)
$-0.58
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CVEO
CVEO
HCM
HCM
Q4 25
$161.6M
$270.8M
Q3 25
$170.5M
Q2 25
$162.7M
$277.7M
Q1 25
$144.0M
$324.5M
Q4 24
$151.0M
Q3 24
$176.3M
Q2 24
$188.7M
$305.7M
Q1 24
$166.1M
Net Profit
CVEO
CVEO
HCM
HCM
Q4 25
$-6.5M
$2.0M
Q3 25
$-455.0K
Q2 25
$-3.3M
$455.0M
Q1 25
$-9.8M
$11.9M
Q4 24
$-15.4M
Q3 24
$-5.1M
Q2 24
$8.2M
$25.8M
Q1 24
$-5.1M
Gross Margin
CVEO
CVEO
HCM
HCM
Q4 25
22.7%
37.7%
Q3 25
25.7%
Q2 25
25.3%
0.1%
Q1 25
20.4%
48.0%
Q4 24
18.6%
Q3 24
21.4%
Q2 24
25.4%
41.1%
Q1 24
21.5%
Operating Margin
CVEO
CVEO
HCM
HCM
Q4 25
-0.1%
-13.2%
Q3 25
4.1%
Q2 25
1.7%
-1.3%
Q1 25
-3.8%
-5.0%
Q4 24
-6.7%
Q3 24
0.0%
Q2 24
6.9%
-9.0%
Q1 24
-1.1%
Net Margin
CVEO
CVEO
HCM
HCM
Q4 25
-4.0%
0.7%
Q3 25
-0.3%
Q2 25
-2.0%
163.8%
Q1 25
-6.8%
3.7%
Q4 24
-10.2%
Q3 24
-2.9%
Q2 24
4.4%
8.4%
Q1 24
-3.1%
EPS (diluted)
CVEO
CVEO
HCM
HCM
Q4 25
$-0.58
$0.00
Q3 25
$-0.04
Q2 25
$-0.25
$0.52
Q1 25
$-0.72
$0.01
Q4 24
$-1.04
Q3 24
$-0.36
Q2 24
$0.56
$0.03
Q1 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CVEO
CVEO
HCM
HCM
Cash + ST InvestmentsLiquidity on hand
$14.4M
$1.4B
Total DebtLower is stronger
$93.2M
Stockholders' EquityBook value
$174.4M
$1.2B
Total Assets
$477.4M
$1.8B
Debt / EquityLower = less leverage
0.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CVEO
CVEO
HCM
HCM
Q4 25
$14.4M
$1.4B
Q3 25
$12.0M
Q2 25
$14.6M
$1.4B
Q1 25
$28.4M
$836.1M
Q4 24
$5.2M
Q3 24
$17.9M
Q2 24
$7.4M
$802.5M
Q1 24
$16.8M
Total Debt
CVEO
CVEO
HCM
HCM
Q4 25
$93.2M
Q3 25
Q2 25
$93.4M
Q1 25
$82.8M
Q4 24
$43.3M
Q3 24
Q2 24
$82.1M
Q1 24
Stockholders' Equity
CVEO
CVEO
HCM
HCM
Q4 25
$174.4M
$1.2B
Q3 25
$182.5M
Q2 25
$209.4M
$1.2B
Q1 25
$220.7M
$759.9M
Q4 24
$236.4M
Q3 24
$282.2M
Q2 24
$297.4M
$740.1M
Q1 24
$297.4M
Total Assets
CVEO
CVEO
HCM
HCM
Q4 25
$477.4M
$1.8B
Q3 25
$491.1M
Q2 25
$508.8M
$1.8B
Q1 25
$423.8M
$1.3B
Q4 24
$405.1M
Q3 24
$477.6M
Q2 24
$483.2M
$1.3B
Q1 24
$513.1M
Debt / Equity
CVEO
CVEO
HCM
HCM
Q4 25
0.08×
Q3 25
Q2 25
0.08×
Q1 25
0.11×
Q4 24
0.18×
Q3 24
Q2 24
0.11×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CVEO
CVEO
HCM
HCM
Operating Cash FlowLast quarter
$19.3M
$8.2M
Free Cash FlowOCF − Capex
$14.5M
$3.4M
FCF MarginFCF / Revenue
8.9%
1.2%
Capex IntensityCapex / Revenue
3.0%
1.8%
Cash ConversionOCF / Net Profit
4.21×
TTM Free Cash FlowTrailing 4 quarters
$2.1M
$-96.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CVEO
CVEO
HCM
HCM
Q4 25
$19.3M
$8.2M
Q3 25
$13.8M
Q2 25
$-2.3M
$-72.9M
Q1 25
$-8.4M
$40.3M
Q4 24
$9.5M
Q3 24
$35.7M
Q2 24
$32.4M
$-39.8M
Q1 24
$6.0M
Free Cash Flow
CVEO
CVEO
HCM
HCM
Q4 25
$14.5M
$3.4M
Q3 25
$8.2M
Q2 25
$-6.8M
$-82.2M
Q1 25
$-13.7M
$32.5M
Q4 24
$1.8M
Q3 24
$28.2M
Q2 24
$27.0M
$-49.9M
Q1 24
$372.0K
FCF Margin
CVEO
CVEO
HCM
HCM
Q4 25
8.9%
1.2%
Q3 25
4.8%
Q2 25
-4.2%
-29.6%
Q1 25
-9.5%
10.0%
Q4 24
1.2%
Q3 24
16.0%
Q2 24
14.3%
-16.3%
Q1 24
0.2%
Capex Intensity
CVEO
CVEO
HCM
HCM
Q4 25
3.0%
1.8%
Q3 25
3.3%
Q2 25
2.8%
3.3%
Q1 25
3.7%
2.4%
Q4 24
5.1%
Q3 24
4.2%
Q2 24
2.8%
3.3%
Q1 24
3.4%
Cash Conversion
CVEO
CVEO
HCM
HCM
Q4 25
4.21×
Q3 25
Q2 25
-0.16×
Q1 25
3.38×
Q4 24
Q3 24
Q2 24
3.93×
-1.54×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons